JAMA Oncology : High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade

Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.

Source: JAMA Specialty Journals Author Interviews - June 16, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts